Your browser is no longer supported. Please, upgrade your browser.
Settings
GNCA Genocea Biosciences, Inc. daily Stock Chart
GNCA [NASD]
Genocea Biosciences, Inc.
Index- P/E- EPS (ttm)-2.04 Insider Own0.10% Shs Outstand27.48M Perf Week6.18%
Market Cap111.02M Forward P/E- EPS next Y-1.61 Insider Trans-65.08% Shs Float24.89M Perf Month-18.71%
Income-57.90M PEG- EPS next Q-0.48 Inst Own64.70% Short Float17.12% Perf Quarter-32.67%
Sales0.00M P/S- EPS this Y-0.90% Inst Trans0.55% Short Ratio7.79 Perf Half Y-9.01%
Book/sh0.67 P/B6.03 EPS next Y10.70% ROA-92.30% Target Price21.25 Perf Year-25.87%
Cash/sh1.28 P/C3.15 EPS next 5Y- ROE-146.40% 52W Range3.28 - 7.29 Perf YTD-1.94%
Dividend- P/FCF- EPS past 5Y-13.10% ROI-77.30% 52W High-44.58% Beta2.41
Dividend %- Quick Ratio3.00 Sales past 5Y-33.60% Gross Margin- 52W Low23.17% ATR0.37
Employees98 Current Ratio3.00 Sales Q/Q- Oper. Margin- RSI (14)33.35 Volatility6.59% 8.83%
OptionableYes Debt/Eq0.90 EPS Q/Q-38.20% Profit Margin- Rel Volume0.41 Prev Close4.19
ShortableYes LT Debt/Eq0.56 EarningsAug 10 Payout- Avg Volume546.86K Price4.04
Recom1.80 SMA20-20.27% SMA50-22.29% SMA200-20.96% Volume223,009 Change-3.58%
Jul-25-17Upgrade Needham Hold → Buy $12
Feb-17-17Downgrade Needham Buy → Hold
Apr-01-16Reiterated Stifel Buy $11 → $13
Dec-17-15Initiated UBS Buy $15
Oct-20-15Reiterated Needham Buy $22 → $15
Oct-19-15Reiterated FBR Capital Outperform $20 → $17
Mar-05-14Initiated Needham Buy $22
Mar-03-14Initiated Stifel Buy $25
Aug-11-17 08:20AM  Today's Research Reports on Stocks to Watch: Genocea Biosciences and Corbus Pharmaceuticals ACCESSWIRE
Aug-09-17 10:25PM  Genocea Biosciences reports 2Q loss Associated Press -14.55%
08:00AM  Genocea Biosciences Reports Second Quarter 2017 Financial Results GlobeNewswire
Jul-28-17 08:00AM  Genocea Biosciences to Highlight GEN-003 Clinical Data at the 42nd Annual International Herpesvirus Workshop GlobeNewswire
Jul-25-17 08:00AM  Todays Research Reports on Trending Tickers: Genocea Biosciences Inc. and Dynavax Technologies Corporation Accesswire
Jul-24-17 05:10PM  Cowen Sings the Praises of Genocea Biosciences Inc (GNCA) Following Positive GEN-003 Phase 2b Data SmarterAnalyst +15.45%
02:22PM  Genocea Biosciences Inc (GNCA): This Analyst Turns Bullish, Sets $12 Target Price SmarterAnalyst
07:00AM  Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes GlobeNewswire
Jun-26-17 08:00AM  Genocea Added to Russell 3000® and Russell 2000® Indices GlobeNewswire
May-04-17 09:25AM  Genocea Biosciences reports 1Q loss Associated Press
07:35AM  Investor Network: Genocea Biosciences, Inc. to Host Earnings Call Accesswire
07:30AM  Genocea Reports First Quarter 2017 Financial Results and Positive Clinical Developments on Lead Candidate GEN-003 in Genital Herpes GlobeNewswire
Apr-30-17 02:00PM  2 'Swing for the Fences' Small Biotechs TheStreet.com
Apr-27-17 08:00AM  Genocea to Host First Quarter 2017 Financial Results Conference Call & Webcast on May 4, 2017 at 9 a.m. ET GlobeNewswire -7.95%
Apr-20-17 08:15AM  GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1% Zacks
Apr-19-17 11:10AM  This Trading-Range Action Is Not Offering Much TheStreet.com +7.07%
Apr-11-17 08:27AM  Genocea Awarded World Vaccine Congress 2017 Industry Excellence Award for Best Therapeutic Vaccine for GEN-003 for Genital Herpes GlobeNewswire +9.15%
Mar-29-17 08:00AM  Genocea to Present at the 16th Annual Needham Healthcare Conference GlobeNewswire +5.51%
Mar-08-17 08:30AM  Genocea Biosciences (GNCA) Jumps: Stock Moves 12% Higher Zacks
Mar-06-17 04:54PM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
08:00AM  Howard Mayer, M.D., of Shire, Joins Genocea Biosciences Board of Directors GlobeNewswire
Mar-01-17 08:00AM  Genocea to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-23-17 01:04PM  GENOCEA BIOSCIENCES, INC. Financials
Feb-22-17 11:49AM  Genocea Biosciences, Inc. :GNCA-US: Earnings Analysis: Q4, 2016 By the Numbers Capital Cube
11:49AM  Genocea Biosciences, Inc. :GNCA-US: Earnings Analysis: Q4, 2016 By the Numbers
Feb-17-17 04:06PM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-K, Annual Report
07:50AM  Genocea Biosciences downgraded by Needham
Feb-16-17 07:44AM  Genocea Biosciences reports 4Q loss Associated Press -9.94%
07:38AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:30AM  Genocea Reports Fourth Quarter and Year-End 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Genocea Biosciences Inc Earnings Release - Time Not Supplied
Feb-09-17 08:00AM  Genocea to Host Fourth Quarter and Year End 2016 Financial Results Conference Call & Webcast on February 16, 2017 GlobeNewswire
Feb-07-17 08:42AM  Should You Sell Genocea Biosciences (GNCA) Before Earnings? Zacks
Jan-09-17 01:23PM  ETFs with exposure to Genocea Biosciences, Inc. : January 9, 2017
Jan-06-17 08:43AM  Genocea Stock Up on Positive Genital Herpes Infections Data -7.20%
Jan-05-17 11:40AM  Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday
06:37AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure
06:30AM  Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial GlobeNewswire
Dec-17-16 04:14PM  How Genocea Biosciences Inc (GNCA) Stacks Up Against Its Peers at Insider Monkey
Dec-16-16 10:15PM  How Smart Money Ranks KVH Industries, Inc. (KVHI) Against Its Peers at Insider Monkey +8.19%
Dec-14-16 04:05PM  Genocea R&D Day Highlighted Lead Program, GEN-003, for the Treatment of Genital Herpes and Introduced Immuno-Oncology Programs & Strategy GlobeNewswire
07:30AM  Genocea Announces Research Collaboration with Checkmate Pharmaceuticals in Advanced Melanoma GlobeNewswire
Dec-08-16 08:00AM  Genocea to Host Virtual R&D Day on December 14th, 2016 GlobeNewswire
Dec-01-16 08:40AM  Genocea Biosciences, Inc. :GNCA-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 -5.47%
Nov-28-16 12:00PM  Edited Transcript of GNCA earnings conference call or presentation 3-Nov-16 1:00pm GMT
Nov-11-16 07:00AM  Genoceas Proprietary ATLAS Technology Identifies Unique Candidate Antigens for Potential Personalized Cancer Vaccines GlobeNewswire +7.75%
Nov-09-16 08:00AM  Genocea to Present at Two Upcoming November Conferences GlobeNewswire
Nov-04-16 08:13AM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-03-16 09:38AM  Genocea Biosciences reports 3Q loss -5.93%
07:40AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:30AM  Genocea Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 Genocea Biosciences Inc Earnings Release - Time Not Supplied
Oct-29-16 02:15PM  Genocea Biosciences Rises on Positive Herpes Trial Results
Oct-28-16 11:53AM  GNC Deal Could Be In Jeopardy, Genocea Taming Herpes, Opexa Not Taming MS, Plus The Latest on Theravance at Insider Monkey
07:30AM  Genocea Presents New 12 month Data on Genital Herpes Immunotherapy GEN-003 at IDWeek 2016 GlobeNewswire
Oct-27-16 08:00AM  Genocea to Host Third Quarter 2016 Financial Results Conference Call & Webcast on November 3, 2016 GlobeNewswire
Sep-29-16 10:45AM  Genocea Biosciences Posts Positive Herpes Trial Results -11.54%
07:34AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure
07:30AM  Genoceas Genital Herpes Immunotherapy GEN-003 Demonstrates Significant Reduction of Viral Shedding in Phase 2b Clinical Trial GlobeNewswire
Aug-09-16 07:30AM  Genocea Congratulates Jessica Baker Flechtner, Ph.D. for Recognition on 2016s 40 Women To Watch Over 40 List GlobeNewswire
Aug-05-16 06:10AM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report +9.82%
Aug-04-16 08:07AM  Genocea Biosciences reports 2Q loss +5.54%
07:45AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:30AM  Genocea Reports Second Quarter 2016 Financial Results GlobeNewswire
Jul-28-16 08:00AM  Genocea to Host Second Quarter 2016 Financial Results Conference Call & Webcast on August 4, 2016 GlobeNewswire
Jul-06-16 08:00AM  Genocea to Present at Cantor Fitzgeralds 2nd Annual Healthcare Conference GlobeNewswire +5.53%
Jun-29-16 07:15AM  7 Stocks Under $10 Making Big Moves
Jun-09-16 05:24PM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.38%
04:30PM  Genocea Appoints Ron Cooper to Board of Directors GlobeNewswire
07:30AM  Genocea Showcases Potential of Genital Herpes Immunotherapy GEN-003 at ASM Microbe 2016 GlobeNewswire
Jun-07-16 04:22PM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-31-16 07:18AM  6 Breakout Stocks Under $10 Set to Soar +18.09%
May-23-16 07:30AM  Genocea Appoints Dr. John E. Bishop as Senior Vice President of Pharmaceutical Sciences GlobeNewswire
May-17-16 08:00AM  Genocea to Present at the 2016 UBS Global Healthcare Conference GlobeNewswire +9.97%
May-06-16 06:09AM  GENOCEA BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report -5.41%
May-05-16 09:29AM  Genocea Biosciences reports 1Q loss
08:14AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:05AM  Genocea Reports First Quarter 2016 Financial Results GlobeNewswire
Apr-28-16 08:00AM  Genocea to Host First Quarter 2016 Financial Results Conference Call & Webcast on May 5, 2016 GlobeNewswire -8.18%
Apr-20-16 08:00AM  Genocea Congratulates Dr. George Siber, 2016 Albert B. Sabin Gold Medal Award Recipient GlobeNewswire
Apr-18-16 09:17AM  Biotech Quietly Preparing Technical Breakouts Accesswire
Apr-13-16 08:03AM  3 Scorching Hot Healthcare Stocks -- Are They Buys? at Motley Fool
Apr-11-16 09:30AM  Zacks Investment Ideas feature highlights: Juno Therapeutics, Genocea Biosciences, Merrimack Pharmaceuticals and BioShares Biotechnology Clinical Trials ETF -14.92%
Apr-06-16 08:00AM  Genocea to Present at the 15th Annual Needham Healthcare Conference GlobeNewswire
Apr-05-16 11:00AM  4 Small Cap Stocks That Are Getting Explosive Volume Today Accesswire
09:21AM  Genocea Biosciences (GNCA) Shares March Higher, Can It Continue?
Apr-04-16 08:42AM  Biotech Firm Receives Key Patent Notice Accesswire +14.79%
Apr-03-16 10:20AM  Top 6 Biopharma Movers of the Past Week at 24/7 Wall St.
Apr-01-16 12:52PM  Why It's Been a Wild Few Days for Genocea Biosciences Inc. at Motley Fool -23.13%
09:35AM  These Stocks Could Double In 2016 - Should They Be In Your Portfolio? Accesswire
07:00AM  Genocea's share price breaks out on herpes vaccine data at bizjournals.com
Mar-31-16 04:55PM  Here???s Why Genocea Biosciences (GNCA) Stock is Skyrocketing Today +94.96%
10:10AM  Genocea Breaks Out With Very Positive Mid-Stage Results at 24/7 Wall St.
10:06AM  Genocea Biosciences (GNCA) Stock Soars on Positive Trial Results at TheStreet
07:18AM  GENOCEA BIOSCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure
07:00AM  Genital Herpes Immunotherapy GEN-003 Shows Sustained Reduction of Viral Shedding Rate, Durable Impact on Clinical Disease 12 Months Post-Dosing GlobeNewswire
Mar-28-16 08:01AM  Biotech Sector Report Analyst Coverage Focusing on Upcoming FDA Decisions Accesswire
Mar-10-16 06:00AM  5 Stocks Under $10 Set to Soar Higher at TheStreet -5.38%
Feb-29-16 08:00AM  Genocea to Present at the Cowen and Company 36th Annual Health Care Conference GlobeNewswire +5.09%
Feb-22-16 12:10PM  Edited Transcript of GNCA earnings conference call or presentation 11-Feb-16 2:00pm GMT -5.12%
Genocea Biosciences, Inc., a biopharmaceutical company, engages in developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. The company uses AnTigen Lead Acquisition System (ATLAS), its proprietary discovery platform to build a pipeline of immunotherapies and its first neoantigen cancer vaccine. Its lead product candidate is GEN-003, a therapeutic vaccine or immunotherapy that is in Phase 2 trial for the treatment of genital herpes infections. The company is also developing GEN-009, which is in pre-clinical stage for the treatment of immuno-oncology-neoantigen; and GEN-007 that is in research stage for the treatment of Epstein-Barr virus. Genocea Biosciences, Inc. was founded in 2006 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Poole JonathanChief Financial OfficerJul 24Option Exercise3.0945,000139,05084,247Jul 24 05:30 PM
Poole JonathanChief Financial OfficerJul 24Sale6.0045,000270,00039,247Jul 24 05:30 PM
Siber GeorgeDirectorMay 19Option Exercise2.6222,28758,35024,304May 22 04:47 PM
Siber GeorgeDirectorMay 18Option Exercise2.1531,04566,72733,062May 22 04:47 PM
Poole JonathanChief Financial OfficerMay 08Sale6.516,21340,44742,747May 10 04:44 PM
HETHERINGTON SETH VChief Medical OfficerNov 09Option Exercise2.025,00010,10026,000Nov 09 05:38 PM
Hoffman Eric SChief Business OfficerNov 08Buy3.593,00010,77011,790Nov 09 05:30 PM
Poole JonathanChief Financial OfficerNov 07Buy3.347,00023,38017,213Nov 09 05:32 PM
Clark William DPresident and CEONov 07Buy3.492,8009,77252,205Nov 09 05:29 PM
Hoffman Eric SChief Business OfficerNov 07Buy3.414,00013,6408,790Nov 09 05:30 PM